The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies - Bajou, K; Masson, V; Gerard, RD; Schmitt, PM; Albert, V; Praus, M; Lund, LR; Frandsen, TL; Brunner, N; Dano, K; Fusenig, NE; Weidle, U; Carmeliet, P; Loskutoff, D; Collen, D; Carmeliet, P; Foidart, JM; Noel, A (J Cell Biol, 2001)